Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02610673

WiCS-LV Post Market Surveillance Registry

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
EBR Systems, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is an observational, prospective, non-randomized collection of defined clinical data under normal conditions of use for the WiCS-LV System, an implantable cardiac pacing system capable of delivering pacing energy to the left ventricle of the heart without using a pacing lead. Patients will be enrolled and followed according to standard of care for 5 years.

Detailed description

A clinical registry will be used to collect data from all implanted patients, at all follow-ups and across all implanting centers. Implant procedure will be according to the 'Instruction for Use' of the system and assessments and follow-ups according the best clinical practice. Anonymized data will be collected on Case Report Forms (CRF) for each patient in the registry. These data will be collected at the time of implant and at scheduled patient in-clinic follow-ups of 1 week, 3 months, 6 months, and 1, 2,3,4,5 years post implant. Patients entering the registry will be given a Registry code suitable to uniquely identify the patient, the implanting center, and the responsible physician. Data will be consolidated into a dataset by the sponsor for analysis purposes. The sponsor may request support from the center to review patient records in order to monitor the data in cases where the data appears incomplete or appears to be inaccurate. The data set will be consolidated such that each implanting center may access its own data, or as mutually agreed between centers, aggregate data. Data may be used by centers for purposes of publication or other objectives of the center.

Conditions

Interventions

TypeNameDescription
DEVICEWiCS-LV SystemImplant of left ventricular receiver-electrode and ultrasound transmitter.

Timeline

Start date
2016-02-08
Primary completion
2027-06-01
Completion
2027-06-01
First posted
2015-11-20
Last updated
2025-03-21

Locations

3 sites across 3 countries: Denmark, Germany, Switzerland

Source: ClinicalTrials.gov record NCT02610673. Inclusion in this directory is not an endorsement.